Denali Therapeutics Inc (DNLI)
15.41
-0.19
(-1.22%)
USD |
NASDAQ |
Apr 30, 16:00
15.41
0.00 (0.00%)
After-Hours: 18:37
Denali Therapeutics Cash from Operations (Quarterly): -98.66M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -98.66M |
| September 30, 2023 | -87.36M |
| June 30, 2023 | -113.17M |
| March 31, 2023 | -58.80M |
| December 31, 2022 | -72.66M |
| September 30, 2022 | -57.05M |
| June 30, 2022 | -42.90M |
| March 31, 2022 | -72.11M |
| December 31, 2021 | -65.49M |
| September 30, 2021 | -41.43M |
| June 30, 2021 | -54.22M |
| March 31, 2021 | -50.24M |
| December 31, 2020 | 513.92M |
| September 30, 2020 | 0.086M |
| Date | Value |
|---|---|
| June 30, 2020 | -43.36M |
| March 31, 2020 | -54.49M |
| December 31, 2019 | -47.64M |
| September 30, 2019 | -30.44M |
| June 30, 2019 | -43.18M |
| March 31, 2019 | -30.32M |
| December 31, 2018 | 93.18M |
| September 30, 2018 | -34.82M |
| June 30, 2018 | -41.82M |
| March 31, 2018 | 33.58M |
| December 31, 2017 | -18.34M |
| September 30, 2017 | -21.92M |
| June 30, 2017 | -17.57M |
| March 31, 2017 | -18.81M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-113.17M
Minimum
Jun 2023
513.92M
Maximum
Dec 2020
-27.33M
Average
-54.22M
Median
Jun 2021
Cash from Operations (Quarterly) Benchmarks
| Halozyme Therapeutics Inc | 102.35M |
| AIM ImmunoTech Inc | -9.758M |
| Perspective Therapeutics Inc | -9.008M |
| Protalix BioTherapeutics Inc | 3.595M |
| Armata Pharmaceuticals Inc | -8.106M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 73.05M |
| Cash from Financing (Quarterly) | 4.705M |
| Free Cash Flow | -370.93M |
| Free Cash Flow Per Share (Quarterly) | -0.7298 |
| Free Cash Flow Yield | -17.40% |